JHU-083

JHU-083 is an experimental drug which acts as a glutaminase inhibitor.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

JHU-083 is an experimental drug which acts as a glutaminase inhibitor. It is a prodrug which is cleaved in vivo to the active form 6-diazo-5-oxo- L -norleucine. It has been researched for the treatment of various neurological conditions such as depression, Alzheimer's disease, and cerebral malaria, as well as multiple sclerosis, atherosclerosis, hepatitis, and some forms of cancer in which it was found to target senescent cells.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1374092633 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.